Regeneron Pharmaceuticals
(REGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,646 | 12,533 | 16,438 | 26,243 | 19,167 |
| Marketable Securities | 26,232 | 75,748 | 66,906 | 78,052 | 2,626 |
| Other current assets | 2,168 | 3,536 | 1,321 | 2,343 | 628 |
| TOTAL | $52,046 | $91,817 | $84,665 | $106,638 | $22,421 |
| Non-Current Assets | |||||
| PPE Net | 27,686 | 22,430 | 10,486 | 5,395 | 2,168 |
| Investments And Advances | 11,280 | 231 | 0 | 0 | 0 |
| Other Non-Current Assets | 3,224 | 3,102 | 2,729 | 1,981 | 849 |
| TOTAL | $42,190 | $25,763 | $13,215 | $7,375 | $3,016 |
| Total Assets | $94,236 | $117,579 | $97,880 | $114,013 | $25,437 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 91 | 0 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 4,971 | 10,313 | 2,450 | 1,576 | 806 |
| Accrued Expenses | 9,752 | 333 | 0 | 324 | 170 |
| Other current liabilities | 0 | 833 | 1,103 | 1,006 | 833 |
| TOTAL | $17,866 | $13,078 | $4,556 | $3,302 | $1,810 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,909 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 1,554 | 3,866 |
| TOTAL | $9,299 | $6,113 | $6,170 | $4,471 | $4,520 |
| Total Liabilities | $27,165 | $19,191 | $10,727 | $7,773 | $6,330 |
| Shareholders' Equity | |||||
| Common Shares | 19 | 12 | 8 | 15 | 5 |
| Retained earnings | -101,098 | -70,443 | -30,559 | -11,447 | -6,979 |
| Other shareholders' equity | -763 | 6 | 6 | 0 | 6,943 |
| TOTAL | $67,071 | $98,388 | $87,153 | $106,240 | $19,108 |
| Total Liabilities And Equity | $94,236 | $117,579 | $97,880 | $114,013 | $25,438 |